Company Announcements ChromaCon granted Knauer a semi-exclusive license in fall 2011 for the Contichrom lab-scale preparative chromatography unit for use in discovery, process development and small-scale production. Bruker disclosed in a fall 2011 SEC filing that it acquired Michrom Bioresources for $3.8 million (see IBO 2/28/11). LabLogic Systems appointed SI Healthcare as a representative for […]
Company Announcements Illumina named Laura Lauman vice president of Marketing in December 2011. She was formerly president of AB SCIEX. In January, Illumina appointed Marc Stapley senior vice president and CFO. Previously, he was senior vice president, Finance, at Pfizer. The Austin Business Journal reported in December 2011 that Thermo Fisher Scientific will hire 150 […]
Responding to the growing instrument market, particularly for life science products, companies continue to expand their operations in India. Life Technologies South Asia Managing Director Devashish Ohri told The Economic Times this month that the firm plans to add up to 100 employees to its Indian operations over the span of this year and next […]
France’s Ministry for Ecology, Sustainable Development, Transportation and Housing has issued a decree requiring the manufacture, importation or distribution of nanomaterials equal to or over 100 grams be reported. The decree also applies to “professional users” and labs that use nanomaterials in those amounts. Reports must be submitted to the French National Agency for Food […]
The central Chinese government has pledged to increase R&D spending 12.4% this year to CNY 228.5 billion ($36.1 billion). Spending for basic research will rise 10.1% to CNY 32.5 billion. In addition, funding for new technologies for agriculture will rise 53% to CNY 10.1 billion. The increases are the latest in China’s continuing growth in […]
Under a European Commission recommendation, 15 new chemicals would be added to the list of 33 pollutants for which surface waters must be monitored by member states. The new chemicals consist of six plant protection substances, three chemicals used in biocidal products, two industrial chemicals, one combustion by-product and, for the first time, three pharmaceutical […]
According to a new working paper from UnitedHealth Group, genetic tests are available for 2,500 conditions. There are between 1,000 and 1,300 genetic tests, but only 400 have evidence-based guidelines. Seven manufacturers lead the market and 1,000 US labs offer such tests. UnitedHealth estimates that in 2010 it spent $500 million on genetic and molecular […]
The FDA approved 34 new molecular entities in its fiscal year ending September 30, 2011; the highest number since 2007. Eleven biologics license applications were approved. Biologic approvals included a high number of orphan indicators and first-time approvals for companies. Seattle Genetics’ Adcetris for treating Hodgkin’s lymphoma and systemic anaplastic large cell lymphoma was approved. […]
In his 2013 budget, President Obama proposed total federal R&D spending of $140.8 billion; a 1.4% increase over 2012 enacted levels. Basic and applied research funding would grow 1.5% and 5.0% to $30.6 billion and $33.4 billion, respectively. Development funding would decrease less than 1% to $74.1 billion. The proposal includes a 10.9% R&D boost […]
Fourth-quarter 2011 IBO Life Science Index sales grew 5.2%, 5.0% excluding currency, to $3,599.71 million. Operating profit expanded 4.4% to $829.93 million, but operating margin slipped 30 basis points to 22.7% of revenues. For 2011, Life Science Index sales grew 7.0%, 5.5% on a currency-neutral basis, to $13,047.60 million. Operating profit rose 5.5% to $2,820.89 […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
